TrialRMD open2022

Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease (RESCUE).

Ai Phuong Tran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.